Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emeline Colomba

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's ChoiceDomenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
Anticancer Research|January 25, 2023
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort StudyHeloïse Bourien, Leïla Bengrine Lefevre, Marie-Ange Mouret-Reynier, et al.
Bulletin Du Cancer|February 26, 2025
[Clinical research in oncology in French Overseas Territories: Challenges, strengths, and available resources]Emeline Colomba, Alexis Vallard, Régine Marlin, et al.
European Urology|June 4, 2023
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZAEmeline Colomba, Sarah Flora Jonas, Jean-Christophe Eymard, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance statusLucía Carril-Ajuria, Emeline Colomba, Carmen Romero-Ferreiro, et al.
JCI Insight|December 15, 2020
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockadeGladys Ferrere, Maryam Tidjani Alou, Peng Liu, et al.
The New England Journal of Medicine|January 19, 2022
Lenvatinib plus Pembrolizumab for Advanced Endometrial CancerVicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Nature Cancer|February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's ChoiceDomenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
Anticancer Research|January 25, 2023
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort StudyHeloïse Bourien, Leïla Bengrine Lefevre, Marie-Ange Mouret-Reynier, et al.
Bulletin Du Cancer|February 26, 2025
[Clinical research in oncology in French Overseas Territories: Challenges, strengths, and available resources]Emeline Colomba, Alexis Vallard, Régine Marlin, et al.
European Urology|June 4, 2023
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZAEmeline Colomba, Sarah Flora Jonas, Jean-Christophe Eymard, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance statusLucía Carril-Ajuria, Emeline Colomba, Carmen Romero-Ferreiro, et al.
JCI Insight|December 15, 2020
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockadeGladys Ferrere, Maryam Tidjani Alou, Peng Liu, et al.
The New England Journal of Medicine|January 19, 2022
Lenvatinib plus Pembrolizumab for Advanced Endometrial CancerVicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Nature Cancer|February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.
Pageof 7